HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of single nucleotide polymorphisms in hematopoietic cell transplant patients affecting early recognition of, and response to, endotoxin.

Abstract
Hematopoietic cell transplant (HCT) is a life-saving therapy for many malignant and non-malignant bone marrow diseases. Associated morbidities are often due to transplant-related toxicities and infections, exacerbated by regimen-induced immune suppression and systemic incursion of bacterial products. Patients undergoing myeloablative conditioning for HCT become endotoxemic and display blood/plasma changes consistent with lipopolysaccharide (LPS)-induced systemic innate immune activation. Herein, we addressed whether patients scheduled for HCT display differences in recognition/response to LPS ex vivo traceable to specific single nucleotide polymorphisms (SNPs). Two SNPs of LPS binding protein (LBP) were associated with changes in plasma LBP levels, with one LBP SNP also associating with differences in efficiency of extraction and transfer of endotoxin to myeloid differentiation factor-2 (MD-2), a step needed for activation of TLR4. None of the examined SNPs of CD14, bactericidal/permeability-increasing protein (BPI), TLR4 or MD-2 were associated with corresponding protein plasma levels or endotoxin delivery to MD-2, but CD14 and BPI SNPs significantly associated with differences in LPS-induced TNF-α release ex vivo and infection frequency, respectively. These findings suggest that specific LBP, CD14 and BPI SNPs might be contributory assessments in studies where clinical outcome may be affected by host response to endotoxin and bacterial infection.
AuthorsEva C Guinan, Christine D Palmer, Christy J Mancuso, Lisa Brennan, Liat Stoler-Barak, Leslie A Kalish, Eugenie E Suter, Leighanne C Gallington, David P Huhtelin, Maria Mansilla, Ralf R Schumann, Jeffrey C Murray, Jerrold Weiss, Ofer Levy
JournalInnate immunity (Innate Immun) Vol. 20 Issue 7 Pg. 697-711 (Oct 2014) ISSN: 1753-4267 [Electronic] United States
PMID24107515 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.
Chemical References
  • Acute-Phase Proteins
  • Carrier Proteins
  • Chemokines
  • Endotoxins
  • Lipopolysaccharide Receptors
  • Membrane Glycoproteins
  • Tumor Necrosis Factor-alpha
  • lipopolysaccharide-binding protein
Topics
  • Acute-Phase Proteins (genetics)
  • Bone Marrow Diseases (genetics, therapy)
  • Carrier Proteins (genetics)
  • Chemokines (metabolism)
  • Cohort Studies
  • Endotoxins (toxicity)
  • Genotype
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Lipopolysaccharide Receptors (genetics)
  • Membrane Glycoproteins (genetics)
  • Polymorphism, Single Nucleotide (genetics)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: